KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables (2020 - 2025)

Historic Receivables for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $32.6 million.

  • Ginkgo Bioworks Holdings' Receivables rose 355.11% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 355.11%. This contributed to the annual value of $33.2 million for FY2024, which is 2164.58% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Receivables of $32.6 million as of Q3 2025, which was up 355.11% from $33.1 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Receivables' 5-year high stood at $178.1 million during Q2 2022, with a 5-year trough of $24.2 million in Q1 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Receivables value was $44.7 million (recorded in 2021), while the average stood at $68.9 million.
  • Its Receivables has fluctuated over the past 5 years, first surged by 71551.46% in 2021, then tumbled by 7094.66% in 2024.
  • Ginkgo Bioworks Holdings' Receivables (Quarter) stood at $136.1 million in 2021, then tumbled by 40.57% to $80.9 million in 2022, then tumbled by 66.31% to $27.3 million in 2023, then rose by 21.65% to $33.2 million in 2024, then decreased by 1.59% to $32.6 million in 2025.
  • Its Receivables was $32.6 million in Q3 2025, compared to $33.1 million in Q2 2025 and $26.3 million in Q1 2025.